Goldman Sachs’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18,261
| Closed | -$204K | – | 5493 |
|
|
2022
Q4 | $204K | Sell |
18,261
-77,425
| -81% | -$865K | ﹤0.01% | 4495 |
|
|
2022
Q3 | $538K | Sell |
95,686
-152
| -0.2% | -$855 | ﹤0.01% | 4194 |
|
|
2022
Q2 | $415K | Sell |
95,838
-1,039
| -1% | -$4.5K | ﹤0.01% | 4504 |
|
|
2022
Q1 | $1.13M | Sell |
96,877
-22,448
| -19% | -$261K | ﹤0.01% | 4016 |
|
|
2021
Q4 | $2.18M | Buy |
119,325
+94,714
| +385% | +$1.73M | ﹤0.01% | 3446 |
|
|
2021
Q3 | $292K | Buy |
24,611
+7,136
| +41% | +$84.7K | ﹤0.01% | 4672 |
|
|
2021
Q2 | $300K | Sell |
17,475
-2,819
| -14% | -$48.4K | ﹤0.01% | 4709 |
|
|
2021
Q1 | $371K | Buy |
20,294
+2,298
| +13% | +$42K | ﹤0.01% | 4530 |
|
|
2020
Q4 | $339K | Sell |
17,996
-9,245
| -34% | -$174K | ﹤0.01% | 4024 |
|
|
2020
Q3 | $575K | Sell |
27,241
-10,157
| -27% | -$214K | ﹤0.01% | 3601 |
|
|
2020
Q2 | $1.08M | Buy |
+37,398
| New | +$1.08M | ﹤0.01% | 3178 |
|